Though vaccine makers are jumping the usual loops of trial development, regulatory agencies are stepping in to ensure that the companies ar...

US-based private equity fund Advent International has signed a definitive agreement to acquire a majority stake in Bharat Serums and Vaccin...

The two funds together hold a 23% stake and the remainder is with the Daftary family.